Bruce F Bell
Examiner (ID: 11075)
Most Active Art Unit | 1741 |
Art Unit(s) | 1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102 |
Total Applications | 2788 |
Issued Applications | 2338 |
Pending Applications | 153 |
Abandoned Applications | 297 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7449237
[patent_doc_number] => 20040067531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => 'Methods of modulating protein tyrosine kinase function with substituted indolinone compounds'
[patent_app_type] => new
[patent_app_number] => 10/458730
[patent_app_country] => US
[patent_app_date] => 2003-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43570
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20040067531.pdf
[firstpage_image] =>[orig_patent_app_number] => 10458730
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/458730 | Methods of modulating protein tyrosine kinase function with substituted indolinone compounds | Jun 10, 2003 | Abandoned |
Array
(
[id] => 7437198
[patent_doc_number] => 20040002524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Benzimidazole compounds and their use as estrogen agonists/antagonists'
[patent_app_type] => new
[patent_app_number] => 10/460565
[patent_app_country] => US
[patent_app_date] => 2003-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35788
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20040002524.pdf
[firstpage_image] =>[orig_patent_app_number] => 10460565
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/460565 | Benzimidazole compounds and their use as estrogen agonists/antagonists | Jun 10, 2003 | Abandoned |
Array
(
[id] => 7403209
[patent_doc_number] => 20040019219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-29
[patent_title] => 'N-alkylated thiazolium salts and process for their preparation'
[patent_app_type] => new
[patent_app_number] => 10/458092
[patent_app_country] => US
[patent_app_date] => 2003-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4784
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20040019219.pdf
[firstpage_image] =>[orig_patent_app_number] => 10458092
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/458092 | N-alkylated thiazolium salts and process for their preparation | Jun 9, 2003 | Abandoned |
Array
(
[id] => 5808363
[patent_doc_number] => 20060094718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'O-substituted hydroxyaryl derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/515622
[patent_app_country] => US
[patent_app_date] => 2003-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59375
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094718.pdf
[firstpage_image] =>[orig_patent_app_number] => 10515622
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515622 | O-substituted hydroxyaryl derivatives | Jun 4, 2003 | Issued |
Array
(
[id] => 7398597
[patent_doc_number] => 20040039037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Heterocyclic compounds and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/455149
[patent_app_country] => US
[patent_app_date] => 2003-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8418
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20040039037.pdf
[firstpage_image] =>[orig_patent_app_number] => 10455149
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/455149 | Heterocyclic compounds and uses thereof | Jun 3, 2003 | Issued |
Array
(
[id] => 7314660
[patent_doc_number] => 20040034078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Benzimidazole inhibitors of poly(ADP-ribosyl) polymerase'
[patent_app_type] => new
[patent_app_number] => 10/453973
[patent_app_country] => US
[patent_app_date] => 2003-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22723
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20040034078.pdf
[firstpage_image] =>[orig_patent_app_number] => 10453973
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/453973 | Benzimidazole inhibitors of poly(ADP-ribosyl) polymerase | Jun 3, 2003 | Abandoned |
Array
(
[id] => 1206412
[patent_doc_number] => 06716993
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-04-06
[patent_title] => 'Polymethine compound and near-infrared absorbing material comprising same'
[patent_app_type] => B2
[patent_app_number] => 10/453514
[patent_app_country] => US
[patent_app_date] => 2003-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6204
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/716/06716993.pdf
[firstpage_image] =>[orig_patent_app_number] => 10453514
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/453514 | Polymethine compound and near-infrared absorbing material comprising same | Jun 3, 2003 | Issued |
Array
(
[id] => 1197000
[patent_doc_number] => 06727246
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-04-27
[patent_title] => '1-(aminoalkyl)-3-sulfonylindole-and-indazole derivatives as 5-hydroxytryptamine-6 ligands'
[patent_app_type] => B2
[patent_app_number] => 10/453009
[patent_app_country] => US
[patent_app_date] => 2003-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9575
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 548
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/727/06727246.pdf
[firstpage_image] =>[orig_patent_app_number] => 10453009
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/453009 | 1-(aminoalkyl)-3-sulfonylindole-and-indazole derivatives as 5-hydroxytryptamine-6 ligands | Jun 2, 2003 | Issued |
Array
(
[id] => 6825788
[patent_doc_number] => 20030236410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-25
[patent_title] => 'Pharmaceutical composition containing bicyclic type compounds'
[patent_app_type] => new
[patent_app_number] => 10/452349
[patent_app_country] => US
[patent_app_date] => 2003-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8376
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20030236410.pdf
[firstpage_image] =>[orig_patent_app_number] => 10452349
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/452349 | Pharmaceutical composition containing bicyclic type compounds | Jun 1, 2003 | Abandoned |
Array
(
[id] => 720321
[patent_doc_number] => 07049333
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-23
[patent_title] => 'Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis'
[patent_app_type] => utility
[patent_app_number] => 10/448851
[patent_app_country] => US
[patent_app_date] => 2003-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18887
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 544
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/049/07049333.pdf
[firstpage_image] =>[orig_patent_app_number] => 10448851
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/448851 | Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis | May 29, 2003 | Issued |
Array
(
[id] => 892328
[patent_doc_number] => 07345078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-18
[patent_title] => 'NF-κB inhibitors and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/449662
[patent_app_country] => US
[patent_app_date] => 2003-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 23
[patent_no_of_words] => 27048
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/345/07345078.pdf
[firstpage_image] =>[orig_patent_app_number] => 10449662
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/449662 | NF-κB inhibitors and uses thereof | May 29, 2003 | Issued |
Array
(
[id] => 7251808
[patent_doc_number] => 20050272936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Imidazolium cxcr3 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/516970
[patent_app_country] => US
[patent_app_date] => 2003-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5571
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272936.pdf
[firstpage_image] =>[orig_patent_app_number] => 10516970
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/516970 | Imidazolium cxcr3 inhibitors | May 28, 2003 | Abandoned |
Array
(
[id] => 6664627
[patent_doc_number] => 20030203953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Repinotan kit'
[patent_app_type] => new
[patent_app_number] => 10/444820
[patent_app_country] => US
[patent_app_date] => 2003-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4589
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20030203953.pdf
[firstpage_image] =>[orig_patent_app_number] => 10444820
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/444820 | Repinotan kit | May 21, 2003 | Abandoned |
Array
(
[id] => 5643343
[patent_doc_number] => 20060281798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Methods of using thiazolidinedithione derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/515087
[patent_app_country] => US
[patent_app_date] => 2003-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20392
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20060281798.pdf
[firstpage_image] =>[orig_patent_app_number] => 10515087
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515087 | Methods of using thiazolidinedithione derivatives | May 15, 2003 | Abandoned |
Array
(
[id] => 7605160
[patent_doc_number] => 07115769
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-03
[patent_title] => 'Synthesis of 2-alkylcysteine via phase transfer catalysis'
[patent_app_type] => utility
[patent_app_number] => 10/438757
[patent_app_country] => US
[patent_app_date] => 2003-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6488
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/115/07115769.pdf
[firstpage_image] =>[orig_patent_app_number] => 10438757
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/438757 | Synthesis of 2-alkylcysteine via phase transfer catalysis | May 14, 2003 | Issued |
Array
(
[id] => 7387048
[patent_doc_number] => 20040082639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-29
[patent_title] => 'N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders'
[patent_app_type] => new
[patent_app_number] => 10/438152
[patent_app_country] => US
[patent_app_date] => 2003-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 93216
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 44
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20040082639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10438152
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/438152 | N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders | May 13, 2003 | Issued |
Array
(
[id] => 1113172
[patent_doc_number] => 06803381
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-12
[patent_title] => 'Carbamic acid derivatives'
[patent_app_type] => B1
[patent_app_number] => 10/438361
[patent_app_country] => US
[patent_app_date] => 2003-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8929
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/803/06803381.pdf
[firstpage_image] =>[orig_patent_app_number] => 10438361
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/438361 | Carbamic acid derivatives | May 13, 2003 | Issued |
Array
(
[id] => 6926551
[patent_doc_number] => 20050239808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur'
[patent_app_type] => utility
[patent_app_number] => 10/514015
[patent_app_country] => US
[patent_app_date] => 2003-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12143
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239808.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514015
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514015 | Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur | May 8, 2003 | Abandoned |
Array
(
[id] => 741688
[patent_doc_number] => 07030144
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-18
[patent_title] => 'Substituted imidazole derivatives: GABAA receptor ligands'
[patent_app_type] => utility
[patent_app_number] => 10/429056
[patent_app_country] => US
[patent_app_date] => 2003-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15578
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/030/07030144.pdf
[firstpage_image] =>[orig_patent_app_number] => 10429056
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/429056 | Substituted imidazole derivatives: GABAA receptor ligands | May 1, 2003 | Issued |
Array
(
[id] => 7402160
[patent_doc_number] => 20040019093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-29
[patent_title] => 'Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them'
[patent_app_type] => new
[patent_app_number] => 10/425210
[patent_app_country] => US
[patent_app_date] => 2003-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4507
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20040019093.pdf
[firstpage_image] =>[orig_patent_app_number] => 10425210
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/425210 | Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them | Apr 28, 2003 | Abandoned |